Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) shares shot up 0.7% during mid-day trading on Friday . The stock traded as high as $1.52 and last traded at $1.52. 104 shares were traded during mid-day trading, a decline of 98% from the average session volume of 6,447 shares. The stock had previously closed at $1.51.
Nutriband Price Performance
The stock’s 50 day moving average is $1.72 and its 200-day moving average is $1.86.
Institutional Investors Weigh In On Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Clear Street Group Inc. purchased a new stake in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 61,590 shares of the company’s stock, valued at approximately $105,000.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
See Also
- Five stocks we like better than Nutriband
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
